Brief: Biorestorative Therapies' BRTX-100 Shows Sustained Pain & Functional Improvements In Chronic Lumbar Disc Disease

Biorestorative Therapies

07/05/2026 19:28

May 7 (Reuters) - BioRestorative Therapies Inc BRTX.O:

BIORESTORATIVE THERAPIES REPORTS EXPANDED PHASE 2 BLINDED DATASET FOR BRTX-100 SHOWING SUSTAINED PAIN AND FUNCTIONAL IMPROVEMENTS IN CHRONIC LUMBAR DISC DISEASE

BIORESTORATIVE THERAPIES INC - 52% OF PATIENTS ACHIEVE ≥50% IMPROVEMENT IN VAS PAIN AND ODI FUNCTION AT 52 WEEKS

BIORESTORATIVE THERAPIES INC - 52-WEEK COHORT INCREASES TO 25 PATIENTS WITH NO DOSE-LIMITING TOXICITY SAFETY SIGNALS

Source text: ID:nGNX4nVmrS

Further company coverage: BRTX.O

 ((Reuters.Briefs@thomsonreuters.com;))